Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
BioCryst Pharmaceuticals | BCRX | 18. nov 2024 | 7.06 | +0.43 |
Biodesix | BDSX | 18. nov 2024 | 1.26 | -6.32 |
Biodexa Pharma ADR | BDRX | 18. nov 2024 | 3.65 | +0.83 |
Biofrontera | BFRI | 18. nov 2024 | 0.67 | -8.45 |
Biogen | BIIB | 18. nov 2024 | 157.94 | -1.28 |
Biohaven | BHVN | 18. nov 2024 | 45.41 | +2.30 |
BioLife Solutions | BLFS | 18. nov 2024 | 20.47 | -2.62 |
BioLineRX ADR | BLRX | 18. nov 2024 | 0.46 | -2.68 |
BioMarin Pharmaceutical | BMRN | 18. nov 2024 | 61.93 | -2.35 |
Biomea Fusion | BMEA | 18. nov 2024 | 6.43 | -1.53 |
Biomerica | BMRA | 18. nov 2024 | 0.34 | -4.04 |
BiomX | PHGE | 18. nov 2024 | 0.58 | -6.98 |
Bionano Genomics | BNGO | 18. nov 2024 | 0.23 | -7.35 |
BioNexus Gene Lab | BGLC | 18. nov 2024 | 0.29 | -2.17 |
Bionomics ADR | BNOX | 18. nov 2024 | 0.29 | -0.93 |
BioNTech ADR | BNTX | 18. nov 2024 | 101.87 | +2.16 |
Biora Therapeutics | BIOR | 18. nov 2024 | 1.81 | -14.62 |
BioRestorative Therapies | BRTX | 18. nov 2024 | 1.36 | -6.55 |
BioShares Biotechnology Clinical Trials Fund | BBC | 18. nov 2024 | 26.10 | -1.62 |
BioShares Biotechnology Products Fund | BBP | 18. nov 2024 | 60.53 | -0.65 |
biote | BTMD | 18. nov 2024 | 6.16 | +14.29 |
Bioventus A | BVS | 18. nov 2024 | 11.25 | +0.09 |
BioVie | BIVI | 18. nov 2024 | 3.41 | +6.90 |
BioXcel Therapeutics | BTAI | 18. nov 2024 | 0.58 | +2.06 |
BIP Bermuda Holdings | BIPI | 18. nov 2024 | 18.65 | -1.04 |
Birkenstock Holding | BIRK | 18. nov 2024 | 46.46 | +1.93 |
Birks Group | BGI | 18. nov 2024 | 1.89 | -2.07 |
Bit Digital | BTBT | 18. nov 2024 | 4.02 | -5.85 |
BIT Mining ADR | BTCM | 18. nov 2024 | 3.00 | +1.69 |
Bit Origin | BTOG | 18. nov 2024 | 1.44 | +5.11 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.